U.S. markets open in 3 hours 49 minutes

CSPC Pharmaceutical Group Limited (1093.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
11.5400.000 (0.00%)
At close: 4:08PM HKT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close11.540
Open11.660
Bid11.520 x 0
Ask11.540 x 0
Day's Range11.400 - 11.700
52 Week Range7.080 - 12.680
Volume36,806,740
Avg. Volume49,247,454
Market Cap138.178B
Beta (5Y Monthly)0.65
PE Ratio (TTM)20.77
EPS (TTM)0.555
Earnings DateAug 24, 2021 - Aug 30, 2021
Forward Dividend & Yield0.25 (2.19%)
Ex-Dividend DateMay 24, 2021
1y Target Est20.92
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • CSPC Pharmaceutical Announces 2020 Interim Results
      PR Newswire

      CSPC Pharmaceutical Announces 2020 Interim Results

      CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group") is pleased to announce its interim results for the six months ended 30 June 2020. For the current period, the Group recorded a revenue of RMB12,590 million, an increase of 12.6% year-on-year, and profit attributable to shareholders of RMB2,314 million, an increase of 23.2% year-on-year. Basic earnings per share was RMB30.97 cents. The Board of Directors has declared an interim dividend of HK6 cents per share for 2020 and proposed a bonus issue.